SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002635
Filing Date
2019-04-26
Accepted
2019-04-26 16:09:50
Documents
6
Period of Report
2019-06-18
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238543zdef14a.htm DEF 14A 236919
2 G535509.JPG g535509.jpg GRAPHIC 12465
3 G664737.JPG g664737.jpg GRAPHIC 8242
4 G234633.JPG g234633.jpg GRAPHIC 6954
5 G86072BCI001.GIF g86072bci001.gif GRAPHIC 93084
6 G86072BCI002.GIF g86072bci002.gif GRAPHIC 96869
  Complete submission text file 0001047469-19-002635.txt   538267
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-38709 | Film No.: 19771855
SIC: 2834 Pharmaceutical Preparations